Congenital adrenal hyperplasia (CAH) due to a deficiency of 21-hydroxylase is the _most common inborn error of the adrenal steroid biosynthetic pathway. The considerable increase of 17ct-hydroxyprogesterone (17-OHP) in the serum of CAH patients has been shown to be already evident at the neonatal period (Chaussain et al., 1974). Consequently, radioimmunoassays have been developed to measure 17-OHP in dried blood samples and have made neonatal screening programmes possible.Two French regional centres for neonatal screening, Lille and Lyon, set up a pilot programme in 1981 to study the different problems raised by CAH mass screening. The present report summarizes the results of CAH screening in different populations and some technical improvements of the RIA determination of 17-OHP in dried blood samples.
METHODCapillary blood samples were collected on the filter paper routinely used for the neonatal screening of phenylketonuria and congenital hypothyroidism, usually on the fifth day of life. 17-OHP was measured by two RIA methods developed in collaboration with Biomerieux (Marcy l'Etoile, France):Tritium method: 17-OHP was eluted from 6mm diameter discs with l mL of phosphate buffer for 30 min and then extracted with 5 mL of ethyl ether using a Sepex apparatus (Biomerieux). Organic phase separation was obtained by freezing the watery phase. The organic phase was evaporated under nitrogen. The extract was dissolved in 100/zL of buffer, then 100/xL of 3H-tracer and 100/zL of antiserum were added. After a 30 min incubation, at room temperature, separation of bound and free was achieved with dextran-charcoal.Iodine-125 method: 17-OHP was eluted from 3 mm diameter discs with 100/xL of phosphate buffer, lOOpL of 12SI-labelled 17-OHP and 100/zL of antiserum. After I hour at 37°C, the bound phase was separated using a further 30min incubation with a polyethyleneglycol second antibody mixture.